TY - JOUR AU - Kleeff, J. AU - Korc, M. AU - Apte, M. PY - 2016 DA - 2016// TI - Pancreatic cancer JO - Nature reviews Disease primers. VL - 2 ID - Kleeff2016 ER - TY - JOUR AU - Rahib, L. AU - Smith, B. D. AU - Aizenberg, R. AU - Rosenzweig, A. B. AU - Fleshman, J. M. AU - Matrisian, L. M. PY - 2014 DA - 2014// TI - Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States JO - Cancer Res VL - 74 ID - Rahib2014 ER - TY - JOUR AU - Oettle, H. AU - Neuhaus, P. AU - Hochhaus, A. PY - 2013 DA - 2013// TI - Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial JO - JAMA VL - 310 ID - Oettle2013 ER - TY - JOUR AU - Neoptolemos, J. P. AU - Stocken, D. D. AU - Bassi, C. PY - 2010 DA - 2010// TI - Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection JO - JAMA VL - 304 ID - Neoptolemos2010 ER - TY - JOUR AU - Uesaka, K. AU - Boku, N. AU - Fukutomi, A. PY - 2016 DA - 2016// TI - Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01) JO - Lancet VL - 388 ID - Uesaka2016 ER - TY - JOUR AU - Conroy, T. AU - Hammel, P. AU - Hebbar, M. PY - 2018 DA - 2018// TI - FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer JO - N Engl J Med VL - 379 ID - Conroy2018 ER - TY - JOUR AU - Neoptolemos, J. P. AU - Palmer, D. H. AU - Ghaneh, P. PY - 2017 DA - 2017// TI - Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial JO - Lancet VL - 389 ID - Neoptolemos2017 ER - TY - JOUR AU - Hoff, D. D. AU - Ervin, T. AU - Arena, F. P. PY - 2013 DA - 2013// TI - Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine JO - New Engl J Med VL - 369 ID - Hoff2013 ER - TY - JOUR AU - Tempero, M. A. AU - Cardin, D. B. AU - Goldstein, D. PY - 2016 DA - 2016// TI - APACT: phase III randomized trial of adjuvant treatment with nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone in patients (pts) with resected pancreatic cancer (PC) JO - J Clin Oncol VL - 34 ID - Tempero2016 ER - TY - JOUR AU - Fathi, A. AU - Christians, K. K. AU - George, B. PY - 2015 DA - 2015// TI - Neoadjuvant therapy for localized pancreatic cancer: guiding principles JO - J Gastrointest Oncol VL - 6 ID - Fathi2015 ER - TY - JOUR AU - Cunningham, D. AU - Allum, W. H. AU - Stenning, S. P. PY - 2006 DA - 2006// TI - Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer JO - N Engl J Med VL - 355 ID - Cunningham2006 ER - TY - JOUR AU - Hofheinz, R. -. D. AU - Wenz, F. AU - Post, S. PY - 2012 DA - 2012// TI - Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial JO - Lancet Oncol VL - 13 ID - Hofheinz2012 ER - TY - JOUR AU - Gillen, S. AU - Schuster, T. AU - Meyer zum Büschenfelde, C. AU - Friess, H. AU - Kleeff, J. PY - 2010 DA - 2010// TI - Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages JO - PLOS Med VL - 7 ID - Gillen2010 ER - TY - JOUR AU - Chang, D. K. AU - Johns, A. L. AU - Merrett, N. D. PY - 2009 DA - 2009// TI - Margin clearance and outcome in resected pancreatic cancer JO - J Clin Oncol VL - 27 ID - Chang2009 ER - TY - JOUR AU - Evans, D. B. AU - Varadhachary, G. R. AU - Crane, C. H. PY - 2008 DA - 2008// TI - Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head JO - J Clin Oncol VL - 26 ID - Evans2008 ER - TY - JOUR AU - Varadhachary, G. R. AU - Wolff, R. A. AU - Crane, C. H. PY - 2008 DA - 2008// TI - Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head JO - J Clin Oncol VL - 26 ID - Varadhachary2008 ER - TY - JOUR AU - Jang, J. Y. AU - Han, Y. AU - Lee, H. PY - 2018 DA - 2018// TI - Oncological benefits of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: a prospective, randomized, open-label, multicenter phase 2/3 trial JO - Ann Surg VL - 268 ID - Jang2018 ER - TY - JOUR AU - Van Tienhoven, G. AU - Versteijne, E. AU - Suker, M. PY - 2018 DA - 2018// TI - Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC-1): a randomized, controlled, multicenter phase III trial [abstract no. LBA4002] JO - J Clin Oncol. UR - https://doi.org/10.1200/JCO.2018.36.18_suppl.LBA4002 DO - 10.1200/JCO.2018.36.18_suppl.LBA4002 ID - Van Tienhoven2018 ER - TY - JOUR AU - Palmer, D. AU - Stocken, D. AU - Hewitt, H. PY - 2007 DA - 2007// TI - A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin JO - Ann Surg Oncol VL - 14 ID - Palmer2007 ER - TY - JOUR AU - Heinrich, S. AU - Pestalozzi, B. AU - Schafer, M. PY - 2008 DA - 2008// TI - Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head JO - J Clin Oncol VL - 26 ID - Heinrich2008 ER - TY - JOUR AU - O’Reilly, E. AU - Perelshteyn, A. AU - Jarnagin, W. PY - 2014 DA - 2014// TI - A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma JO - Ann Surg VL - 260 ID - O’Reilly2014 ER - TY - JOUR AU - Lutfi, W. AU - Talamonti, M. S. AU - Kantor, O. PY - 2016 DA - 2016// TI - Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head JO - Surgery VL - 160 ID - Lutfi2016 ER - TY - JOUR AU - Mokdad, A. A. AU - Minter, R. M. AU - Zhu, H. PY - 2017 DA - 2017// TI - Neoadjuvant therapy followed by resection versus upfront resection for resectable pancreatic cancer: a propensity score matched analysis JO - J Clin Oncol VL - 35 ID - Mokdad2017 ER - TY - STD TI - National Comprehensive Cancer Network. NCCN guidelines for patients: pancreatic cancer. 2017. https://www.nccn.org/patients/guidelines/pancreatic/files/assets/basic-html/page-1.html. UR - https://www.nccn.org/patients/guidelines/pancreatic/files/assets/basic-html/page-1.html ID - ref24 ER - TY - JOUR AU - Al-Hawary, M. M. AU - Francis, I. R. AU - Chari, S. T. PY - 2014 DA - 2014// TI - Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association JO - Radiology VL - 270 ID - Al-Hawary2014 ER - TY - JOUR AU - Ryan, R. AU - Gibbons, D. AU - Hyland, J. M. PY - 2005 DA - 2005// TI - Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer JO - Histopathology VL - 47 ID - Ryan2005 ER - TY - JOUR AU - Chuong, M. D. AU - Frakes, J. M. AU - Figura, N. PY - 2015 DA - 2015// TI - Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer JO - J Gastrointest Oncol VL - 7 ID - Chuong2015 ER - TY - JOUR AU - Vickers, M. M. AU - Lee, C. AU - Tu, D. PY - 2016 DA - 2016// TI - Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3 JO - Pancreatology VL - 16 ID - Vickers2016 ER - TY - JOUR AU - Tajima, H. AU - Ohta, T. AU - Kitagawa, H. PY - 2012 DA - 2012// TI - Pilot study of neoadjuvant chemotherapy with gemcitabine and oral S-1 for resectable pancreatic cancer JO - Exp Ther Med VL - 3 ID - Tajima2012 ER - TY - JOUR AU - Raut, C. P. AU - Tseng, J. F. AU - Sun, C. C. PY - 2007 DA - 2007// TI - Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma JO - Ann Surg VL - 246 ID - Raut2007 ER - TY - JOUR AU - Hartwig, W. AU - Hackert, T. AU - Hinz, U. PY - 2011 DA - 2011// TI - Pancreatic cancer surgery in the new millennium: better prediction of outcome JO - Ann Surg VL - 254 ID - Hartwig2011 ER - TY - BOOK PY - 2014 DA - 2014// TI - Cancer of the exocrine pancreas, ampulla of Vater and distal common bile duct. Structured reporting protocol PB - Royal College of Pathologists of Australasia CY - Sydney ID - ref32 ER - TY - JOUR AU - Shinoto, M. AU - Yamada, S. AU - Yasuda, S. PY - 2013 DA - 2013// TI - Phase 1 trial of preoperative, short-course carbon-ion radiotherapy for patients with resectable pancreatic cancer JO - Cancer VL - 119 ID - Shinoto2013 ER - TY - JOUR AU - Turrini, O. AU - Ychou, M. AU - Moureau-Zabotto, L. PY - 2010 DA - 2010// TI - Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: new neoadjuvant regimen was safe and provided an interesting pathologic response JO - Eur J Surg Oncol VL - 36 ID - Turrini2010 ER - TY - JOUR AU - Alvarez-Gallego, R. AU - Cubillo, A. AU - Garralda, E. PY - 2016 DA - 2016// TI - Pathological response to neoadjuvant gemcitabine plus nabpaclitaxel in pancreatic adenocarcinoma to improve survival JO - J Clin Oncol VL - 34 ID - Alvarez-Gallego2016 ER - TY - JOUR AU - Ielpo, B. AU - Duran, H. AU - Diaz, E. PY - 2016 DA - 2016// TI - Preoperative treatment with gemcitabine plus nab-paclitaxel is a safe and effective chemotherapy for pancreatic adenocarcinoma JO - Eur J Surg Oncol VL - 42 ID - Ielpo2016 ER - TY - JOUR AU - MacKenzie, S. AU - Zen, H. AU - McCahill, L. E. PY - 2013 DA - 2013// TI - A pilot phase II multicenter study of nab-paclitaxel (Nab-P) and gemcitabine (G) as preoperative therapy for potentially resectable pancreatic cancer (PC) JO - J Clin Oncol VL - 31 ID - MacKenzie2013 ER - TY - JOUR AU - Sliesoriatis, S. AU - Desai, N. V. AU - Trevino, J. G. PY - 2014 DA - 2014// TI - Final results for gemcitabine with nab-paclitaxel in neoadjuvant treatment of resectable pancreatic adenocarcinoma: GAIN-1 study JO - J Clin Oncol VL - 32 ID - Sliesoriatis2014 ER - TY - JOUR AU - Chandrasegaram, M. D. AU - Goldstein, D. AU - Simes, J. PY - 2015 DA - 2015// TI - Meta-analysis of radical resection rates and margin assessment in pancreatic cancer JO - Br J Surg VL - 102 ID - Chandrasegaram2015 ER - TY - JOUR AU - Konstantinidis, I. T. AU - Warshaw, A. L. AU - Allen, J. N. PY - 2013 DA - 2013// TI - Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a ‘true’ R0 resection? JO - Ann Surg VL - 257 ID - Konstantinidis2013 ER - TY - JOUR AU - Mathur, A. AU - Ross, S. B. AU - Luberice, K. PY - 2014 DA - 2014// TI - Margin status impacts survival after pancreaticoduodenectomy but negative margins should not be pursued JO - Am Surg VL - 80 ID - Mathur2014 ER - TY - JOUR AU - Verbeke, C. AU - Lohr, M. AU - Karlsson, J. S. AU - Chiaro, M. PY - 2015 DA - 2015// TI - Pathology reporting of pancreatic cancer following neoadjuvant therapy: challenges and uncertainties JO - Cancer Treat Rev VL - 41 ID - Verbeke2015 ER - TY - JOUR AU - Sohal, D. AU - McDonough, S. AU - Ahmad, S. A. PY - 2019 DA - 2019// TI - SWOG S1505: Initial findings on eligibility and neoadjuvant chemotherapy experience with mfolfirinox versus gemcitabine/nab-paclitaxel for resectable pancreatic adenocarcinoma JO - J Clin Oncol VL - 37 ID - Sohal2019 ER - TY - JOUR AU - Mornex, F. AU - Girard, N. AU - Scoazec, J. Y. PY - 2006 DA - 2006// TI - Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: the French SFRO-FFCD 97-04 phase II trial JO - Int J Radiat Oncol Biol Phys VL - 65 ID - Mornex2006 ER - TY - JOUR AU - Scheithauer, W. AU - Ramanathan, R. K. AU - Moore, M. PY - 2016 DA - 2016// TI - Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: phase III MPACT trial JO - J Gastrointest Oncol. VL - 7 ID - Scheithauer2016 ER - TY - JOUR AU - Serrano, P. E. AU - Herman, J. M. AU - Griffith, K. A. PY - 2014 DA - 2014// TI - Quality of life in a prospective multi-center phase II trial of neoadjuvant full dose gemcitabine, oxaliplatin and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma JO - Int J Radiat Oncol Biol Phys VL - 90 ID - Serrano2014 ER - TY - JOUR AU - Liao, W. C. AU - Chien, K. L. AU - Lin, Y. L. PY - 2013 DA - 2013// TI - Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis JO - Lancet Oncol VL - 14 ID - Liao2013 ER - TY - JOUR AU - Conroy, T. AU - Desseigne, F. AU - Ychou, M. PY - 2011 DA - 2011// TI - FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer JO - N Engl J Med VL - 364 ID - Conroy2011 ER - TY - JOUR AU - Tempero, M. A. AU - Reni, M. AU - Riess, H. PY - 2019 DA - 2019// TI - Randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) for surgically resected pancreatic adenocarcinoma JO - J Clin Oncol VL - 37 ID - Tempero2019 ER - TY - JOUR AU - Versteijne, E. AU - Vogel, J. A. AU - Besselink, M. G. PY - 2018 DA - 2018// TI - Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer JO - Br J Surg VL - 105 ID - Versteijne2018 ER - TY - JOUR AU - Ettrich, T. J. AU - Berger, A. W. AU - Muche, R. PY - 2014 DA - 2014// TI - NEONAX: Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: a phase II study of the AIO Pancreatic Cancer Group JO - J Clin Oncol VL - 32 ID - Ettrich2014 ER -